Shockwave Medical Further Validates Utility of Intravascular Lithotripsy in Lower Limb Lesions in Late-Breaking Presentation at VIVA 2024
DISRUPT BTK II, a global post-market study, finds favorable 30-day outcomes for peripheral IVL in the most challenging calcified lesions, including patients with CLTI
LAS VEGAS, November 4, 2024
– Shockwave Medical, Inc., part of Johnson & Johnson...
Zur Pressemeldung auf www.jnj.com